Practice Administration

Managing Self-Pay Accounts Receivable in Oncology

Matt Terry, MBA, BSRT

September 2017, Vol 7, No 9 - Billing/Accounts Receivable

Self-pay accounts receivable in healthcare includes true self-pay (ie, patients with no health insurance) and the patient responsibility after insurance. In the past, health insurance plan benefits covered much more of the patient’s bill, up to 90% or more; however, in the past few years, high-deductible health plans have become more common and more attractive for plan members because of lower monthly premiums. Thus, the patient responsibility after insurance has shifted from 10% of the collectible accounts receivable to upwards of 30%. [ Read More ]

Drug Pricing Under the Trump Administration

Meg Barbor, MPH

July 2017, Vol 7, No 7 - Health Policy

Washington, DC—A change in leadership brings with it healthcare reform and potential changes in drug pricing in the United States, said Jessica Turgon, MBA, Principal, ECG Management Consultants, Washington, DC, at the 2017 Association of Community Cancer Centers meeting. Ms Turgon discussed what this transition of power means for cancer centers, and what oncology providers can realistically expect under the Trump administration. [ Read More ]

Input from Patients, Families, and Caregivers Can Enhance the Quality of Patient Care

Meg Barbor, MPH

May 2017, Vol 7, No 5 - Quality Care

Orlando, FL—Establishing a Patient and Family Advisory Council for Quality (PFACQ) is one of the most direct routes to true patient-centered care, said Kate Niehaus, MBA, Chair, PFACQ, Memorial Sloan Kettering Cancer Center (MSKCC), New York City, at the 2017 ASCO Quality Care Symposium. Ms Niehaus discussed how PFACQs can be used as a mechanism for the patient’s voice. [ Read More ]

Integrating Patient-Reported Outcomes into Clinical Practice in Oncology

Meg Barbor, MPH

May 2017, Vol 7, No 5 - Quality Care

Orlando, FL—The term “patient-reported outcome” has become ubiquitous in cancer care. Patient-reported outcomes (PROs) are still in the early stages of being integrated into quality assessment programs and routine clinical practice, but engaging patients through PROs can be an invaluable tool for assessing and improving the quality of symptom management, said Ethan M. Basch, MD, MSc, FASCO, Director, Cancer Outcomes Research Program, UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, at the 2017 ASCO Quality Care Symposium. [ Read More ]

The Limitations of Big Data in Cancer Care

Jessica Miller

February 2017, Vol 7, No 2 - Practice Management

There is little chance of escaping the spell that big data has cast over the healthcare industry. “Anytime you listen to any conference, just about every panel, just about every speaker at some point brings up the idea of the use of data for value based care, for value contracts, for quality measures, for new indications for drugs,” said Brad Hirsch, MD, Senior Medical Director, Flatiron Health, New York, NY, at the Sixth Annual Conference of the Association for Value-Based Cancer Care. [ Read More ]